ReviewFrontiers in oncology2022

Neuro-immune-endocrine mechanisms with poor adherence to aromatase inhibitor therapy in breast cancer.

Li Huifang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.